• Morbidity catamnesis and neuropsychic development in children after undergoing congenital pneumonia during the first year of life 
To content

Morbidity catamnesis and neuropsychic development in children after undergoing congenital pneumonia during the first year of life 

SOVREMENNAYA PEDIATRIYA.2015.7(71):107-110; doi 10.15574/SP.2015.71.107 
 

Morbidity catamnesis and neuropsychic development in children after undergoing congenital pneumonia during the first year of life 
 

Znamenskaya T. K., Kurilina T. V., Zbrozhik E. V., Pyatchanin Yu. S.

SI «Institute of Pediatrics, Obstetrics and Gynecology NAMS of Ukraine», Kiev, Ukraine 
 

Objective. To analyze the development and incidence of children in the first year of life, depending on the severity of the stroke congenital pneumonia and its treatment. 
 

Patients and methods. The observational prospective study of morbidity and neuropsychic development of children with congenital pneumonia during the first year of life is conducted. It was conducted on the base of follow-up supervision cabinet of an Advisory Clinic in Zhytomyr Regional Children's Hospital. A dynamic observation of 68 children is conducted. Children were divided into two groups according to the severity of clinical signs of the severity of under-going congenital pneumonia. The subject of the study was to investigate the frequency of infectious diseases, anemia, allergic reactions, disbіosis and neurological disorders; to study the physical and psychological development; neurosonography analysis, morphometric parameters of thymus and the number of major studies of immune cells. 
 

Results. Follow-up monitoring during the first year of life of children after undergoing congenital pneumonia had shown a significantly fewer number of healthy children in comparison with children of the control group at 2 months (14.7% versus 88.0% of children, p <0.05) and at 12 months (48.5% against 76.0% of children of children, p <0.05). 
 

Conclusions. Children after undergoing congenital pneumonia have objective reasons to be referred to the high risk group of such diseases as infectious, allergies, prenatal disorders of the central nervous system and to be subject of dispensary supervision at the stage of children's clinic by a pediatrician, neurologist and immunologist. 
 

Key words: disease, congenital pneumonia, children. 
 

REFERENCES

1. Волосовец ОП, Кривопустов СП, Корнійчук ОВ и др. 2007. Сучасний стан та перспективи респіраторної терапії в інтенсивній неонатології. Здоровье ребёнка. 4(7): 106—111.

2. Сенаторова ГС, Паращук ЮС, Рига ОО та ін. 2006. Досвід ведення новонароджених з тяжкими розладами дихання. Актуальні питання неонатології. Матер ІV Конгресу неонатологів України. Київ: 130—131.

3. Знаменська ТК, Жданович ОІ, Коломійченко ТВ. 2006. Основні напрямки розвитку неонатології на сучасному етапі. Журн практ лікаря. 5—6: 2—4.

4. Феклин ВА, Сиренко ТВ, Кандиба ВП и др. 2009. Совершенствование лечения пневмонии у новорожденных путём использования современных медицинских технологий. Здоровье ребёнка. 6(9): 105—108.

5. Шунько ЄЄ, Костюк ОО, Краснова ЮЮ та ін. 2010. Перинатальна інфекція, викликана стрептококом групи В. Совр педиатрия. 2(30): 170—174.

6. Vohr B, Wright LL, Hack M et al. 2004. Follow-up care of high-risk infants. Pediatrics. 5: 1377—1397.